Clinical Trials Directory

Trials / Completed

CompletedNCT05006092

Surveillance Modified by Artificial Intelligence in Endoscopy (SMARTIE)

Multicenter Evaluation Study of the CADe System ENDOMIND in Surveillance Endoscopy for Colorectal Cancer in German Outpatient Cohort

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,149 (actual)
Sponsor
Wuerzburg University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Evaluation of an artificial intelligence system for polyp detection (CADe)

Detailed description

We aim to evaluate the artificial intelligence system ENDOMIND that supports endoscopist in detection of polyps during surveillance endoscopy for colorectal cancer. 1070 patients out of 6 gastroenterologic practice are randomized 1:1 for conventional surveillance colonoscopy vs. surveillance with AI support. Primary endpoint is Adenoma detection rate.

Conditions

Interventions

TypeNameDescription
DEVICEENDOMINDCADe system for Polyp detection

Timeline

Start date
2021-09-01
Primary completion
2022-11-30
Completion
2022-11-30
First posted
2021-08-16
Last updated
2023-04-27

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05006092. Inclusion in this directory is not an endorsement.